{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:05Z","timestamp":1759336505671,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.nrl.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T01:28:54Z","timestamp":1520558934000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuritis \u00f3ptica en pediatr\u00eda: experiencia en 27 a\u00f1os y protocolo de actuaci\u00f3n"],"prefix":"10.1016","volume":"36","author":[{"given":"L.","family":"Monge Galindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Mart\u00ednez de Morent\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pueyo Royo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Garc\u00eda I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"S\u00e1nchez Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00f3pez-Pis\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Pe\u00f1a-Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2018.01.008_bib0185","unstructured":"Dale RC, Vincent A. Clinics, in Developmental Medicine N.o. 184-185. Inflammatory and autoimmune disorders of the nervous system in children. En: Banwell BL, Buncic R, editores. Optic neuritis in Children. London: Mac Keith Press; 2010."},{"key":"10.1016\/j.nrl.2018.01.008_bib0190","series-title":"Neuro-Ophthalmology: Diagnosis and Management","article-title":"Visual loss: Optic neuropathies","author":"Liu","year":"2001"},{"key":"10.1016\/j.nrl.2018.01.008_bib0195","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0200","first-page":"1896","article-title":"Demand for neuropediatric services in a general referral hospital. III. Diagnosis.","volume":"25","author":"L\u00f3pez-Pis\u00f3n","year":"1997","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nrl.2012.11.005","article-title":"Changes in the demand for paediatric neurology care in a spanish tertiary care hospital over a 20-year period","volume":"29","author":"Monge Galindo","year":"2014","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2018.01.008_bib0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.optom.2013.12.008","article-title":"Optic neuritis in pediatric population: A review in current tendencies of diagnosis and management","volume":"7","author":"P\u00e9rez-Cambrod\u00ed","year":"2014","journal-title":"J Optom"},{"key":"10.1016\/j.nrl.2018.01.008_bib0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2003.11.011","article-title":"Clinical characteristics of Japanese children with optic neuritis","volume":"31","author":"Mizota","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1091-8531(99)70078-9","article-title":"Optic neuritis in children: Clinical features and visual outcome","volume":"3","author":"Brady","year":"1999","journal-title":"J AAPOS."},{"key":"10.1016\/j.nrl.2018.01.008_bib0225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.wnl.0000224757.69746.fb","article-title":"The clinical features, MRI findings, and outcome of optic neuritis in children","volume":"67","author":"Wilejto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3928\/0191-3913-20020101-07","article-title":"Optic neuritis in Asian children","volume":"39","author":"Hwang","year":"2002","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.nrl.2018.01.008_bib0235","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1212\/NXI.0000000000000356","article-title":"Optical coherence tomography and visual evoked potentials in pediatric MS","volume":"4","author":"Waldman","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.nrl.2018.01.008_bib0240","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/jnnp.74.11.1577","article-title":"Spinal cord MRI in clinically isolated optic neuritis","volume":"74","author":"Dalton","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrl.2018.01.008_bib0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaapos.2011.05.020","article-title":"Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies","volume":"15","author":"Waldman","year":"2011","journal-title":"J AAPOS."},{"key":"10.1016\/j.nrl.2018.01.008_bib0250","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1212\/01.wnl.0000344163.65326.48","article-title":"Pediatric optic neuritis: Brain MRI abnormalities and risk of multiple sclerosis","volume":"72","author":"Bonhomme","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2018.01.008_bib0255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00415-005-0655-9","article-title":"Predicting the outcome of optic neuritis: Evaluation of risk factors after 30 years of follow-up","volume":"252","author":"Nilsson","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0260","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis","volume":"61","author":"Pirko","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0265","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1755-3768.2008.01259.x","article-title":"Anti-aquaporin-4 antibody-positive optic neuritis","volume":"87","author":"Takagi","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nrl.2018.01.008_bib0280","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2018.01.008_bib0290","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","article-title":"Risk factors for developing multiple sclerosis after childhood optic neuritis","volume":"49","author":"Lucchinetti","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pediatrneurol.2015.05.010","article-title":"Optic Neuritis in Korean Children: Low Risk of Subsequent Multiple Sclerosis","volume":"53","author":"Kim","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0300","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2018.01.008_bib0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/08820530390895172","article-title":"Optic neuritis in adults and children","volume":"18","author":"Boomer","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0161-6420(90)32583-6","article-title":"Bilateral postinfectious optic neuritis and intravenous steroid therapy in children","volume":"97","author":"Farris","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0315","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.46.4.1173","article-title":"Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis","volume":"46","author":"Hahn","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2018.01.008_bib0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0387-7604(99)00011-X","article-title":"A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment","volume":"21","author":"Apak","year":"1999","journal-title":"Brain Dev."},{"key":"10.1016\/j.nrl.2018.01.008_bib0325","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0887-8994(99)00042-9","article-title":"Intravenous immunoglobulin theraphy in acute disseminated encephalomyelitis","volume":"21","author":"Nishikawa","year":"1999","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.nrl.2018.01.008_bib0330","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1542\/peds.110.2.e21","article-title":"Acute disseminated encephalomyelitis in children","volume":"110","author":"Murthy","year":"2002","journal-title":"Pediatrics."},{"key":"10.1016\/j.nrl.2018.01.008_bib0335","doi-asserted-by":"crossref","first-page":"284","DOI":"10.33588\/rn.6306.2016247","article-title":"Tuberculous hypophysitis mimicking Tolosa-Hunt s\u00edndrome","volume":"63","author":"Monge-Galindo","year":"2016","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrl.2018.01.008_bib0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(01)01209-0","article-title":"Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nrl.2018.01.008_bib0345","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2018.01.008_bib0350","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2018.01.008_bib0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.23575","article-title":"Canadian Pediatric Demyelinating Disease Network. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis","volume":"72","author":"Sadaka","year":"2012","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrl.2018.01.008_bib0360","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2003.10.056","article-title":"First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability","volume":"144","author":"Mikaeloff","year":"2004","journal-title":"J Pediatr"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485318300239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485318300239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:11:41Z","timestamp":1759324301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485318300239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0213485318300239"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2018.01.008","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuritis \u00f3ptica en pediatr\u00eda: experiencia en 27 a\u00f1os y protocolo de actuaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}